MIT cell biologist named head of $2B NIH unit

The NIH has named Chris Kaiser as the new director of its National Institute of General Medical Sciences, the $2 billion institute that funds research in a range of fields including genetics and computational biology. Kaiser is a cell biologist at MIT, where his research has focused on protein folding in yeast. NIH release

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.